jurpsy schreef:
www.masshightech.com/stories/2009/05/...Lundbeck, a wholly owned subsidiary of H. Lundbeck A/S in Denmark, will pay the $1 million for GTC’s first supply of ATryn.
In March, GTC closed its contract with LEO Pharma A/S, relating to the commercialization and development of ATryn in Europe, Canada and the Middle East. GTC alleged that LEO is “in breach of its obligations,” and it is pursuing damages as a result.